Competition/Antitrust Competition/Antitrust

A selling shareholder in Newen Studios’ acquisition of Johnson Production Group

On July 25, 2024, Newen Studios announced it signed an agreement to acquire a majority stake in Johnson Production Group. This strategic acquisition is part of Newen Studio’s ambition to develop and acquire Global IP and further strengthen Newen’s position in the dynamic and highly resilient...

Lead Office: Montreal Date Announced: July 25, 2024 Value: --

Béton Provincial in connection with its acquisition of CRH Canada Group Inc.

On May 14, 2024, Béton Provincial announced its acquisition of most of CRH Canada’s assets located in Quebec and Newfoundland and Labrador, and a terminal located in the state of New York. Through this acquisition, Béton Provincial has advanced its vertical integration of its operations...

Lead Office: Montreal Date Announced: May 14, 2024 Value: -

Emera Inc. in the sale of its interest in the Labrador Island Link

Osler advised Emera Inc. in the sale of its minority equity interest in the Labrador Island Link, a critical energy transmission asset in Newfoundland and Labrador, to Kohlberg Kravis Roberts & Co. for a total transaction value of $1.19 billion. The transaction value was made up of $957...

Lead Office: Toronto Date Announced: June 4, 2024 Value: $1.19 billion

Battery Ventures in its $150 million acquisition of TrueContext Corporation

On May 16, 2024, Battery Ventures announced the completion of the previously announced plan of arrangement to acquire all of the issued and outstanding common shares of TrueContext Corporation for $1.07 per share in cash. Upon completion of the transaction, TrueContext became a privately held...

Lead Office: Toronto Date Closed: May 16, 2024 Value: $150 million

Cuboh in its acquisition by ChowNow

On March 28, 2024, Cuboh announced its acquisition by ChowNow, a leader in online ordering and marketing platforms for independent restaurants. This strategic move aims to integrate Cuboh’s point-of-sale (POS) integration solutions with ChowNow’s platform, enhancing ChowNow’s suite of digital...

Lead Office: Vancouver Date Closed: March 28, 2024 Value: -

Fusion Pharmaceuticals in its acquisition by AstraZeneca

On March 19, 2024, Fusion Pharmaceuticals announced that it entered into a definitive agreement to be acquired by AstraZeneca for a transaction value of approximately US$2.4 billion. Through this acquisition, AstraZeneca is taking a significant leap towards its goal of revolutionizing cancer...

Lead Office: Toronto Date Closed: -- Value: US$2.4 billion

iCON Infrastructure in its investment in QSL

On February 23, 2024, QSL International Ltd. announced the arrival of new shareholders: funds advised by iCON Infrastructure LLP, CDPQ and the QSL management shareholders already active in the company's capital. QSL is a North American port terminal and logistics operator headquartered in...

Lead Office: Toronto Date Closed: February 23, 2024 Value: -

Metro Supply Chain in its acquisition of SCI Group Inc.

On January 9, 2024, Metro Supply Chain announced it entered into an agreement to acquire SCI Group Inc. from Canada Post and Purolator Holdings Ltd. With this acquisition, Metro Supply Chain’s position will be strengthened for offering contract logistics services. The combined entities will...

Lead Office: Montreal Date Announced: January 9, 2024 Value: -

Boart Longyear in the sale of its shares to American Industrial Partners Capital Fund

On December 27, 2023, Boart Longyear agreed to the sale of its outstanding and issued common shares to American Industrial Partners Capital Fund for approximately US $371 million. Boart Longyear anticipates that the deal will be advantageous to their clients and employees through AIP’s strategy...

Lead Office: Vancouver Date Announced: December 27, 2023 Value: US$371 million

Inversago Pharma in its US$1.075 billion business combination with Novo Nordisk

On August 10, 2023, Inversago Pharma announced its business combination with Nova Nordisk for US$1.075 billion pursuant to the completion of certain development and commercial milestones. This acquisition will strengthen Nova Nordisk’s clinical development and research capability for obesity and...

Lead Office: Montreal Date Closed: -- Value: US$1.075 billion